表紙
市場調査レポート

薬剤自己投与市場:薬剤、適応、市場および予測

Drug Self-Administration to 2022

発行 Greystone Research Associates 商品コード 228362
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
薬剤自己投与市場:薬剤、適応、市場および予測 Drug Self-Administration to 2022
出版日: 2015年01月01日 ページ情報: 英文
概要

当レポートでは、薬剤自己投与市場について調査分析を行い、市場動向、市場促進因子、部門別分析、技術と市場の見通し、主要企業のプロファイルなどをまとめ、お届けいたします。

エグゼクティブサマリー

薬剤市場のダイナミクス

  • 進化する薬剤開発と市場因子
  • マネージドケアと処方の動向
  • 薬剤自己投与の需要因子
  • 慢性疾患と自己投与
  • 生物学的製剤の増加
  • 送達装置技術と進化

薬剤自己投与市場の製品部門と促進因子

  • 自己投与注入型製品
    • 市場部門の力学
    • プレフィルドシリンジ(PFS)
      • ガラス製
      • プラスチック製
    • 自己注射器
    • ペン型注射器
      • 再利用型
      • 使い捨て型
    • 無針注射器 (NFI)
      • 競合的NFI治療セグメント
      • NFIメーカーのプロファイル
  • 自己投与吸入型製品
    • 市場部門の力学
    • 上気道市場
    • 全身/深肺市場
    • 吸入技術と市場の見通し
    • 吸入型製品部門
      • ドライパウダー吸入器
      • 定量吸入器
      • ネブライザー
    • 性能因子
    • 生体利用性
    • 投与の再現性
    • 活性化合物の安定性
  • 経皮投与製品
    • 市場部門の力学
    • 処方薬パッチのデザインと技術
    • 能動輸送パッチ技術
    • 処方薬パッチの発展要因
    • 主な経皮治療市場
    • 経皮薬剤の主要企業プロファイル

薬剤の自己投与:治療部門/見通し

  • ADHD
  • 抗凝血剤
  • 関節炎
  • ぜんそく/COPD
  • 心臓血管
  • 避妊
  • 嚢胞性線維症
  • 糖尿病
  • 造血剤
  • 肝炎
  • ホルモン治療/補充
  • 多発性硬化症
  • 神経疾患
  • 骨粗鬆症
  • 疼痛管理
  • 乾癬
  • 性の健康

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: DSA345R

While alternative methods for delivering therapeutics to patients have had some notable successes, most drugs continue to be delivered orally. Because they cannot tolerate the first-pass metabolism of the digestive tract, the recent escalation in new biological drugs, including antibodies and recombinant proteins, is placing renewed emphasis on alternate delivery technologies. Now a number of factors are converging to create both risk and opportunity for drug makers and their delivery device partners. These include new classes of drugs for previously refractory conditions, the growing trend toward self-administration for chronic diseases, shifting patient demographics in industrial countries, caregiver safety legislation, and continued pressure to control healthcare costs. These factors are giving rise to a new generation of sophisticated, application-specific injection, inhalation and transdermal drug products designed to satisfy caregiver and patient preferences while addressing managed care initiatives and the formulation limitations of new classes of therapeutic drugs. Because of their ability to safely and reliably satisfy treatment protocols and compliance goals, non-oral drug delivery products will have a significant impact on the future of drug self-administration.

Highlights

  • Provides detailed analysis of drug self-administration market segments, market dynamics and market demographics
  • Analyzes therapeutic demand drivers and evaluates commercial drug products in more than two dozen major self-administration therapeutic segments
  • Analyzes design factors, material selection issues, technologies and market development issues for injection devices, inhalation devices and transdermal drug products designed for self-administration
  • Charts product data, market share, and forecasts to 2022
  • Profiles self-administration drug product and device participants, their product development activities, business strategies, and corporate alliances and affiliations

Table of Contents

Executive Summary

Drug Market Dynamics

  • Evolving Drug Development and Market Factors
  • Managed Care and Prescribing Trends
  • Drug Self-Administration Demand Factors
    • Shifting Patient Demographics
    • Chronic Disease and Self-administration
    • Biological Drugs Proliferating
    • Delivery Device Technology & Evolving

Drug Self-Administration Product Segments and Market Drivers

  • Injectable Drug Self-Administration
  • Market Sector Dynamics
  • Prefilled Syringes (PFS)
    • Glass PFS
    • Plastic PFS
    • Autoinjectors
  • Pen Injectors
    • Reusable Pens
    • Disposable Pens
  • Needle-free Injectors (NFI)
    • Competitive NFI Therapeutic Segments
    • Needle-free Company Profiles
  • Inhaled Drug Self-Administration Products
  • Market Sector Dynamics
    • The Upper Respiratory Market
    • The Systemic/Deep Lung Market
  • Inhaler Technology and Market Prospects
    • Inhaler Product Segments
      • Dry Powder Inhalers
      • Metered Dose Inhalers
      • Nebulizers
    • Performance Factors
      • Bioavailability
      • Dose Reproducibility
      • Active Compound Stability
  • Transdermal Drug Products
  • Market Sector Dynamics
  • Prescription Patch Design & Technology
  • Active Transport Patch Technologies
  • Prescription Patch Development Factors
  • Key Transdermal Therapeutic Markets
  • Transdermal Product Company Profiles

Drug Self-Administration - Therapeutic Sector Analysis & Forecasts

  • ADHD
  • Anticoagulants
  • Arthritis
  • Asthma/COPD
  • Cardiovascular
  • Contraception
  • Cystic Fibrosis
  • Diabetes
  • Hematopoietics
  • Hepatitis
  • Hormone Therapy/Replacement
  • Multiple Sclerosis
  • Neurology
  • Osteoporosis
  • Pain Management
  • Psoriasis
  • Sexual Health
Back to Top